Your browser doesn't support javascript.
loading
The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition.
Vanneste, Marion; Venzke, Anita; Guin, Soumitra; Fuller, Andrew J; Jezewski, Andrew J; Beattie, Sarah R; Krysan, Damian J; Meyers, Marvin J; Henry, Michael D.
Afiliación
  • Vanneste M; Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City IA, United States.
  • Venzke A; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.
  • Guin S; Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City IA, United States.
  • Fuller AJ; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.
  • Jezewski AJ; Department of Chemistry, Saint Louis University, Saint Louis, MO, United States.
  • Beattie SR; Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
  • Krysan DJ; Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
  • Meyers MJ; Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
  • Henry MD; Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City IA, United States.
Front Oncol ; 13: 1295185, 2023.
Article en En | MEDLINE | ID: mdl-37909019

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos